A Comprehensive, Ethnically Diverse Library of Sickle Cell Disease-Specific Induced Pluripotent Stem Cells Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • Sickle cell anemia affects millions of people worldwide and is an emerging global health burden. As part of a large NIH-funded NextGen Consortium, we generated a diverse, comprehensive, and fully characterized library of sickle-cell-disease-specific induced pluripotent stem cells (iPSCs) from patients of different ethnicities, β-globin gene (HBB) haplotypes, and fetal hemoglobin (HbF) levels. iPSCs stand to revolutionize the way we study human development, model disease, and perhaps eventually, treat patients. Here, we describe this unique resource for the study of sickle cell disease, including novel haplotype-specific polymorphisms that affect disease severity, as well as for the development of patient-specific therapeutics for this phenotypically diverse disorder. As a complement to this library, and as proof of principle for future cell- and gene-based therapies, we also designed and employed CRISPR/Cas gene editing tools to correct the sickle hemoglobin (HbS) mutation.

authors

  • Park, Seonmi
  • Gianotti-Sommer, Andreia
  • Molina-Estevez, Francisco Javier
  • Vanuytsel, Kim
  • Skvir, Nick
  • Leung, Amy
  • Rozelle, Sarah S
  • Shaikho, Elmutaz Mohammed
  • Weir, Isabelle
  • Jiang, Zhihua
  • Luo, Hong-Yuan
  • Chui, David Hing-kwei
  • Figueiredo, Maria Stella
  • Alsultan, Abdulraham
  • Al-Ali, Amein
  • Sebastiani, Paola
  • Steinberg, Martin H
  • Mostoslavsky, Gustavo
  • Murphy, George J

publication date

  • April 2017

has subject area